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Caspase-inhibited cells induced to die may exhibit the traits of either apoptosis or necrosis or both, simultaneously. However, mechanisms
regulating the commitment to these distinct forms of cell death are barely identified. We found that staurosporine induced both apoptotic and
necrotic traits in U937 cells exposed to the caspase inhibitor benzyloxycarbonyl-Val-Ala-DL-Asp(OMe)-fluoromethylketone. Morphology and
flow cytometry revealed that individual cells exhibited either apoptotic or necrotic traits, but not the mixed phenotype. Inhibition of cathepsin
activity by benzyloxycarbonyl-Phe-Ala-fluoromethylketone rendered caspase-compromised cells resistant to staurosporine-induced apoptosis, but
switched the cell death form to necrosis. Inhibition of heat shock protein 90 kDa (Hsp90) chaperon activity by geldanamycin conferred resistance
to necrosis in caspase-compromised cells but switched the cell death form to apoptosis. Combination of benzyloxycarbonyl-Phe-Ala-
fluoromethylketone and geldanamycin halted the onset of both forms of cell death by saving mitochondrial trans-membrane potential and
preventing acidic volume (lysosomes) loss. These effects of benzyloxycarbonyl-Phe-Ala-fluoromethylketone and/or geldanamycin on cell death
were restricted to caspase-inhibited cells exposed to staurosporine but influenced neither only the staurosporine-provoked apoptosis nor hydrogen
peroxide (H2O2)-generated necrosis. Our results demonstrate that the staurosporine-induced death pathway bifurcates in caspase-compromised
cells and commitment to apoptotic or necrotic phenotypes depends on cathepsin protease or Hsp90 chaperon activities.
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It is accepted that the main, but not obligate, hallmark of
apoptosis is the activation of caspases resulting in cleavage of a
selective pool of proteins, loss of phospholipid assymetry in the
plasma membrane and early oligonucleosomal DNA fragmen-
tation. These events are accompanied by characteristic morpho-
logical changes of the cell, such as shrinkage and condensation.
On the contrary, necrosis is marked by oncosis and dilution in the
morphological appearance, accompanied by early loss of the
integrity of plasma membrane and intracellular compartments.
Usually these traits of apoptosis and necrosis appear in separate
cells, but sometimes they may appear combined in individual
cells as atypical forms of cell death [11,25,55,60].
When caspase activity is suppressed in cells (e.g. in the pres-
ence of caspase inhibitor), an apoptosis-prone stimuli (especially
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necrotic(-like) cell death forms depending on the cell type
[18,26,57]. The mechanisms regulating the commitment to these
distinct cell death forms are studied mainly in death receptor
models, with the use of caspase inhibitors or genetically modified
cells but barely explored with other type of cell death inducers
[12,21,31–33,38,56].
Staurosporine (STS) – a poorly selective inhibitor of protein
kinases – is a widely applied model compound for inducing cell
death [50]. Treatment with STS induces the mitochondrial
pathway of apoptosis, activates the Bax protein [64] and promotes
its translocation to the mitochondria [48]. Consequently, the outer
membrane of the mitochondria becomes permeabilized, allowing
the release of proapoptotic proteins such as cytochrome c, Omi/
HtrA2 and AIF [8,43,45,49,58]. Cytochrome c initiates apopto-
some formation, activation of caspase-9 and the executioner
caspases (-3, -6, -7). Caspases process their selective target pro-
teins, thereby evoking the maturation of the apoptotic morphol-
ogy [65].
Recent results, however, revealed that STS could induce
regulated cell death even in the presence of caspase inhibitors.
The mechanism and the morphological appearance of this cell
death were differently defined in the various cell models. In
caspase-compromised cells, STS could induce neither the
proteolytic processing of caspase target proteins nor the large
scale DNA fragmentation, but initiated prominent chromatin
condensation [2,12]. However, the STS-induced cell death forms
were distinct in various caspase-compromised models. In some
cases, apoptotic (-like) [4,9,14,15,62] and in other cases, necrotic
(-like) [1,63] cell death forms were concluded to be dominant.
Previously, we have reported that CA-074Me abrogated STS-
induced cell death (both apoptotic and necrotic) in caspase-
inhibited leukemia cells independently from the inhibitory effect
of CA-074Me on cathepsin B [36]. This study was designed to
reveal how individual caspase-inhibited U937 cells committed
to apoptosis or to necrosis or maybe simultaneously to a mixed
phenotype when exposed to STS and what role cystein cathep-
sins other than cathepsin B play in these processes.
2. Materials and methods
2.1. Materials
z-Val-Ala-Asp(OMe)-fluoromethylketone (z-VAD.fmk) and Z-Phe-Ala-
FMK (z-FA.fmk) were purchased from both Enzyme System Product (MP
Biomedicals, Solon, OHUSA) andBachem (Bubendorf, Switzerland). z-DEVD-
amc, z-RR-amc, z-FR-amc were from Bachem. Staurosporine and geldanamycin
were from Sigma (St. Louis, MO, USA).
2.2. Cell culture
U937 promonocytic cell line was cultured in RPMI 1640 (Sigma) with 10%
heat inactivated fetal bovine serum (Sigma), 2 mM L-glutamine and 100 μg/mL
penicillin–streptomycin (Sigma) at 5% CO2 and 37 °C in a humidified chamber.
Cells were regularly tested for the expression of some humanCD antigens: CD45
(+); CD33(+); CD13(+); CD34(−); CD14(−); CD4(−). Antibodies were directly
labeled with fluorochrome and purchased from Becton-Dickinson (Franklin
Lakes, NJ, USA). For treatment, cells were plated in 0.5 mL onto 48-well
suspension plate (Greiner) at 3×105 cells/mL as control and 5×105 cells/mL for
geldanamycin (GA; 1 μM) pretreatment for 12 h as geldanamycin inhibited cellproliferation. Then cells were exposed to z-FA.fmk (z-FA; 1 μM) and/or z-VAD
(OMe).fmk (z-VAD.fmk; 50 μM) 30 min before staurosporine (STS; 1 μM).
Cells were incubated with STS for 8 h.
2.3. Detection of cell death associated functional changes by flow
cytometry
The samples were detected with FACScalibur or FACScan flow cytometers
(Becton Dickinson). Data were analyzed with WINLIST software (VERITY
Software House, Topsham, USA). The following standard light filters were
applied to fluorescence channels: FL1: 530/30 nm; FL2: 585/42 nm; FL3:
650LP. Analysis was performed on the amplitude (height, H) of the fluorescence
signal in log scale. Doublet discrimination panel was set on FL2 channel for
detection of FL2A (area) and FL2W (width) characteristics of the fluorescence
signal in linear scale. The terms of various flow cytometric representations used
in the following paragraphs include sample preparation, the profile of flow
cytometric detection, gating strategy and data analysis.
2.4. [PI uptake] representation of plasma membrane damage
Treated cells were stained with 0.5 mL PBS containing 5 mM glucose and
10 μg/mL propidium iodide (PI) (Sigma) in the plate, and incubated for 15 min
on 37 °C before measurement. Necrotic (PI+) cells usually lost light scatter
intensity therefore they mixed up with debris in the [FSC, SSC] two-
dimensional parameter diagram. For gating necrotic cells out of debris we
applied [FSC, FL3H] diagram where necrotic cells contained high amount of
DNA could be separated from debris contained low amount of DNA. Gated cells
were analyzed on FL2H log scale histograms and data were presented as
percentage of cells in the marked region of the histogram (Fig. 2D).
Alternatively, samples stained with DiOC6(3) or annexin V-FITC together
with PI was also exploited for analysis in [PI uptake] representation.
2.5. [Annexin V-FITC, PI] representation of phosphatidylserine
distribution in the plasma-membrane
The assay was performed according to the suggestions of the vendor (Alexis
Biochemicals, Lausen, Switzerland). Treated cells were stained with 0.5 mL
PBS containing 5 mM glucose and 10 μg/mL PI in the plate and incubated for
10 min on 37 °C. After centrifugation (300×g/2 min), the cells were suspended
in 400 μL binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2).
80 μL of the sample in binding buffer was mixed with 20 μL annexin V-FITC
solution (5 μL annexinV-FITC was dissolved in 15 μL binding buffer). After
10 min incubation in the dark additional 400 μL of binding buffer (containing
1 μg/mL PI) was added to the samples and measured immediately. The [FSC,
FL3H] diagram was applied for gating and the gated cells were analyzed in
[FL1H, FL2H] log scale two-dimensional diagram. Auto-fluorescence of the
cells was positioned in first decade, and compensation for FITC fluorescence in
the FL2 channel was applied. Data were presented as percentage of cells in the
marked regions of the diagram (Fig. 4A).
2.6. [DiOC6(3)] representation of the mitochondrial trans-membrane
potential
Samples were prepared according to Darzynkiewicz and Bender [10], with
modifications. Treated cells were stained with 0.5 mL PBS containing 5 mM
glucose, 10 nM DiOC6(3) (Sigma) and 10 μg/mL PI in the plate and incubated
for 15 min on 37 C° before harvesting and measurement without washing. Cells
were gated in [FSC, FL3H] diagram, analyzed on FL1H log scale histograms
and the data were presented as mean fluorescence intensity of the whole gated
cell population (Fig. 7A, B).
2.7. [AO red] representation of the volume of acidic compartments
Samples were prepared according to Traganos and Darzynkiewicz [54], with
modifications. Acridine orange (AO) is a metachrome dye providing green
fluorescence at low concentration (e.g. when intercalated into ds-DNA) and
red fluorescence at high concentration (e.g. when amassed in the acidic
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containing 5 mM glucose and 5 μg/mL AO (Sigma) in the plate and incubated
for 15 min on 37 C°. After centrifugation (300×g/2 min) the cells were
suspended in 1 mL PBS containing 5 mM glucose and measured immediately.
Cells were gated in [FL1H, FL3H] diagram for discriminating cells with high
DNA content from debris with low amount of DNA. The gated populations were
analyzed on FL3H log scale histograms and the data were presented as mean
fluorescence intensity of the whole population (Fig. 7E, F).
2.8. [Sub-G1] representation of oligonucleosomal DNA fragmentation
Samples were prepared according to Gong et al. [22]. Treated cells were
centrifuged (300×g/2 min) and the pellets were suspended in 1 mL 70% ethanol
(−20 °C), let the cells fixed on room temperature for 30 min and stored on
−20 °C. Oligonucleosomal DNA fragments were extracted from ethanol-fixed
cells in 750 μL extraction buffer containing 200 mM Na2HPO4/citric acid
(pH=7.8) and 10 μg/mL RNAse A (Sigma) for 15 min, then stained with PI
(propidium iodide, 5 μg/mL for final concentration) for at least 10 min before
measurement. Cells were gated in (FSC, FL2H) diagram for discriminating
debris and analyzed on FL2H log scale histogram as percentage of cells in the
marked, sub-G1 region.
2.9. [SSC, DNA content] representation of light scatter change and
DNA fragmentation
Cells were fixed, stained and gated according to the [sub-G1] representation.
The gated populations were analyzed on the (SSC, FL2H) diagrams marked
regions as (SSCnorm, DNAlow) for apoptotic cells, (SSClow, DNAnorm) for
necrotic cells and (SSClow, DNAlow) for cells with a mixed, atypical phenotype
and percentage of cells in this regions were presented (Fig. 2D).
2.10. Cell cycle analysis
Cells were fixed and stained according to [sub-G1] representation. Cells
were gated in (FSC, FL2H) diagram in combination with (FL2A, FL2W)
diagram for inclusion of sub-G1 dead cells and exclusion of doublets. The gated
population was analyzed on FL2A linear scale histogram, markers were set on
the border of G1-S and on the first quarter of S cell cycle phase and percentage
of the cell in this region was presented.
2.11. Cleaved PARP western blot analysis
0.5×106 cells were treated with drugs as described above. At the end of the
incubation cells were washed in PBS and pelleted (100 g, 4 min). The pellet was
resuspended in 50 μL 2× Laemmli buffer (62.5 mM Tris–HCl, pH 6.8, 2% SDS,
25% glycerol, 0.01% Bromophenol Blue) with 5% mercaptoethanol. Each
samples was boiled for 3 min. Electrophoresis was performed in a 10%
polyacrylamide gel. Rabbit polyclonal antibody against PARP (#9542, Cell
Signaling Technology; Kvalitex, Budapest, Hungary) was used to detect full
length PARP (116 kDa) and cleaved fragment (89 kDa). Horseradish
peroxidase-conjugated goat anti-rabbit IgG (#7074, Cell Signaling Technology)
was employed as secondary antibody. Detection was performed using ECL
western blotting substrate (#32106, PIERCE). Visualization was done by Kodak
Image Station 4000 MM and Kodak Molecular Imaging Software 4.0.3 was
used to determine the density of the bands. The density of the fragment was
expressed as percentage of the sum of the density of the fragment and the full
length PARP bands.
2.12. Protease activity assays
The treated cells (0.5×106 cells/mL) were incubated for different time points
and then washed in PBS two times (300 g/2 min). Samples were suspended in
100 μL caspase buffer (50 mM HEPES (pH 7.4), 100 mM NaCl, 0.1% (w/v)
CHAPS, 10% (w/v) sucrose, +10 mM DTT (freshly added)) or cathepsin buffer
(Na2HPO4/NaH2PO4 pH6, 1 mM EDTA, 1 mM DTT (freshly added)). After
transferring samples into 96-well plates Triton X-100 (0.2%) were added, and
cell lysis was completed by repeated pipetting. Caspase substrate z-DEVD.amc(20 μM) or cathepsin substrates z-FR.amc (50 μM) or z-RR.amc (50 μM) were
added, and fluorescence intensities of libareted AMC was recorded for 15 min
by a fluorescence plate reader Fluoroskan Ascent (Thermo Fisher Scientific,
Waltman MA, USA). Protease activity was determined from the slope of the
AMC fluorescence. Activity was presented as percentage of control, vehicle-
treated samples.
2.13. Agarose gel electrophoresis
The samples were dissolved in 100microL/106 cells buffer solution containing:
100mMEDTA, 10 mMTRIS (pH=8) 0.5% SDS (and proteinase K in 0.1 mg/mL
concentration added freshly ) at least 1 h at 50 °C. Then RNase (DNase free) were
added to the samples in 0.2 mg/mL concentration and cells were kept on 30 °C
overnight. The samples were run on 1% agarose gel and then were stained in
ethidium bromide (for 15 min) and detected under UV light.
2.14. Light microscopic studies
Cytospin preparations were fixed in methanol, stained with hematoxylin–
eosin, then were dehydrated with ethanol, acetone and xilol. The morphological
changes of apoptosis were studied by light microscopy. 200 cells per slide were
counted and the number of apoptotic and necrotic cells were determined. Cells
were categorized according to Daugas et al. [12]: stage I, apoptotic cell
condensed moderately (including smooth nuclei); stage II. apoptotic cells had
full blown nuclear condensation (pyknosis) and formation of nuclear apoptotic
bodies (karyorrhexis). Necrosis was characterized by cell swelling and blurred
plasma membrane. Cells with washed out cytoplasm, the so-called ghosts, were
identified as late necrotic cells.
2.15. Electron microscopy
Samples (0.5×106 cells) were spun (200×g/5 min) onto slide (slides were
covered with parlodion and heated for better adhesion) then fixed in
glutaraldehyde (2.5%, 30 min, 4 °C) and kept in PBS overnight at 4 °C. Next
day the slides were incubated in OsO4 (dissolved in PBS) for at least 90 min then
washed in PBS (for 10 min). The samples were dehydrated in rising
concentration of ethanol (50–75–96–100%), then EPON-812 (1:1 in abs.
ethanol) was dropped to the samples for 1 h. Capsules containing EPON-812
were placed onto samples and were kept in 60 °C for a day to let the resin
polymerized. Samples were separated from slides by cooling in liquid nitrogen.
Thin sections were cut by LKB-Ultrotom-3A. The slices were placed on a grid.
Samples were treated (2% uranil-acetat for 10 min, lead citrate for 2 min) to get
contrast and then examined under transmission electron microscope (Philips,
CM-10).
2.16. Statistics
All experiments were repeated at least twice. Significance was determined
by Student's t-probe (two tailed, paired) using Microsoft Excel and the indicated
significance on graphs are: Pb0.05 (⁎); Pb0.01 (⁎⁎); Pb0.001 (⁎⁎⁎).
3. Results
3.1. Staurosporine induced delayed apoptotic and necrotic cell
death forms in caspase- compromised cells
We performed time-course experiments to determine the
kinetic appearance of cell death features in U937 cells exposed
to STS (1 μM) in the absence or presence of pan caspase inhibitor
z-VAD.fmk (50μM). STS alone induced caspase 3-likeDEVDase
activity after 2 h, accompanied by small scale DNA fragmentation
detected by flow cytometry as sub-G1 cells (Fig. 1A). Plasma
membrane damage occurred only several hours later, possibly as a
sign of secondary necrosis (PI+ cells) detected by PI staining.
Fig. 1. Staurosporine-induced delayed apoptotic and necrotic cell death forms in caspase-compromised cells. U937 cells were exposed to STS (1 μM) in the presence or
absence of z-VAD.fmk (z-VAD) (50 μM) or DMSO as vehicle. Time kinetics of cell death (sub-G1: cells with fragmented DNA; PI+: cells with plasmamembrane damage)
and effector caspase (DEVDase) activity (detectedwith z-DEVD.amc fluorogenic substrate) in samples exposed to (A) STS or (B) STS+z-VAD.fmk. (n=2). (C) Cells were
treated as indicated and stained with hematoxylin–eosin. Arrows indicate apoptotic (white) or necrotic (black) cells. (D) Counting of apoptotic and necrotic cells based on
morphological criteria (n=2) after 8 h treatments. (E) The same experiments evaluated in [sub-G1] and [PI uptake] flow cytometric death profiles.
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activity for up to 15 h (Fig. 1B). However, we could detect a
gradually increasing number of sub-G1 cells and PI-positive cells
after 5 h of treatment, indicating the formation of apoptotic cells
and necrotic cells in synchrony. Morphological investigation of
hematoxylin–eosin-stained samples revealed that STS generated
a great number of cells with stage II apoptotic nuclear morphol-
ogy that included nuclear fragmentation (karyorrhexis) and
condensation [12] (Fig. 1C). The ratio of cells with stage II
apoptotic morphology was in good correlation with sub-G1 cells
(Fig. 1D–E). At 4 h of treatment, z-VAD.fmk inhibited the STS-
provoked manifestation of karyorrhexis but allowed (at least
partially) the cell and nuclear condensation to proceed, the sign of
stage I apoptosis (Fig. 1C). However, stage II cells appeared later
at 8 h of treatment, frequently with dominant nuclear condensa-
tion on the periphery of the nuclei (Fig. 1C). The number of cells
with nuclear condensation correlatedwell with the number of sub-
G1 cells (Fig. 1D–E).
3.2. STS-induced apoptotic or necrotic phenotypes related to
distinct caspase- compromised cells
Electron microscopy confirmed that STS+z-VAD.fmk-treated
U937 cells became either apoptotic (A) (with a similar phenotype
to STS exposed cells) or necrotic (N) with non-condensed,
smooth chromatin without hetero-chromatin and cytoplasm
without a resolved structure (Fig. 2A). In these cells, the nucleusdouble bilayer membrane was often split, the intermembrane
space was dilated, and the cytoplasm was partially or entirely
detached from the nucleus (black arrows, Fig. 2A).
Searching discriminative properties of cell death forms, we
observed that unfixed, PI-positive necrotic cells showed not
only the well-known loss of forward (light) scatter (FSC)
property, but also considerable loss of side (light) scatter (SSC)
property detected by flow cytometry, after STS treatment of
caspase compromised cells (Fig. 2B). Interestingly, after
ethanol fixation and processing of samples according to [sub-
G1] representation, this population of cells reserved the
properties of diminished SSC, while PI stained these cells
with the same fluorescence intensity as non-dead (ND) (or
untreated) cells with fully retained DNA content (SSClow,
DNAnorm) (Fig. 2B). The percentage of this (SSClow, DNAnorm)
population in fixed samples correlated well with the percentage
of the PI-positive population in vitally PI-stained samples (Fig.
2C). The loss of the SSC property of necrotic caspase-com-
promised cells in flow cytometry was possibly related to the
loss of the cytoplasm and/or the loss of heterochromatin
observed with electron microscopy (Fig. 2A). In apoptotic cells,
the normal SSC property was well preserved after ethanol
fixation either in STS- or STS+z-VAD.fmk-exposed samples
after 8 h of treatment (SSCnorm, DNAlow) (Fig. 2D). When cells
were treated with STS for prolonged time (20 h), secondary
necrosis ensued apoptosis (Fig. 2D). But post-apoptotic necrotic
cells lost their SSC value only gradually and this was possibly
Fig. 2. STS-induced apoptotic or necrotic phenotypes related to distinct caspase-compromised cells. (A) U937 cells were exposed to STS (1 μM) in the presence or
absence of z-VAD.fmk (50 μM) for 8 h. Samples were prepared for ultrastructural investigation. Black arrows indicate unstuck nucleus membrane. A: apoptotic, N:
necrotic cell. (B) Cells were exposed to STS (1 μM) in the presence of z-VAD.fmk (50 μM) for 8 h and prepared for flow cytometry measurement. PI-stained
UNFIXED samples were presented in FL2-SSC cytogram (SSC in linear scale). PI-stained ETHANOL FIXED cells evaluated in [SSC, DNA content] representation
(SSC in logarithmic scale). Inserted values on representative histograms show the percentage of the marked population. A: apoptotic, N: necrotic, ND: not dead cells.
(C) Correlation between absolute percentage of PI+ cells in unfixed samples and SSC low intensity cells in ethanol fixed samples. Points represent the various
treatments indicated in Fig. 4C column diagrams. (D) Cells were exposed to STS (1 μM) for 8 or 20 h or H2O2 (2.5 mM) for 8 h and prepared for flow cytometry
measurement. Histograms of PI-stained UNFIXED samples evaluated in [PI uptake] representation. Histograms of PI-stained ETHANOL FIXED cells evaluated in
[SSC, DNA content] representation. Inserted values on representative histograms show the percentage of the marked population.
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cell structure. In the case of H2O2-provoked necrosis (2.5 mM,
8 h), a comparable ratio of cells lost their plasma membrane
integrity and their SSC property. However, the lost SSC intensity
was considerably less in necrotic cells exposed to H2O2 than in
necrotic cells generated by STS+z-VAD.fmk. This difference
may signify some variance in the activated necrotic pathways.
Our data indicate that the STS+z-VAD.fmk-induced cell
death pathway bifurcates in individual cells and commitment to
apoptosis is associated with high grade DNA fragmentation
while primary necrosis is associated with considerable loss of
SSC (in correlation with plasma membrane damage).
3.3. STS-induced cell death is associated with cystein cathepsin
protease activity in caspase-compromised cells
To explore the mechanistic elements of cell death in caspase-
compromised cells, we performed DNA gel electrophoresis andPARP cleavage western blot assays. The appearance of nucle-
osomal DNA ladder formation and PARP cleavage confirmed
the apoptotic features of STS-induced cell death. Both DNA
laddering and PARP processing were only partially reduced in
the presence of z-VAD.fmk (Fig. 3A–B). Nucleosomal DNA
fragmentation and the size of cleaved PARP, as well as the
correlation of DNA fragmentation with PARP cleavage at
variable concentrations of z-VAD.fmk (Fig. 3C), support the
assumption of the presence of caspase-like protease activity in
caspase-compromised cells, even when cell lysates were free of
detectable DEVDase activity (Fig. 3C). To resolve this dis-
crepancy, we looked for other protease activity in U937 cells that
may be responsible for PARP cleavage. Though lysosomal
cystein cathepsins reportedly have affinity for z-VAD.fmk (or its
precursor form z-VAD(OMe).fmk) [42,44], we assessed the
cathepsin (FRase and RRase) activity in cells treated with
increasing concentrations of z-VAD.fmk. In comparison to fully
eliminated DEVDase (Fig. 3C) or RRase (not shown) activity, a
Fig. 3. Assessment of protease and DNase activities. (A, B) U937 cells were
exposed to STS (1μM) in the presence or absence of z-VAD.fmk (z-VAD) (50μM)
for 4 and 8 h. Samples were harvested for (A) DNA agarose gel electrophoresis,
(B) western blot analysis and flow cytometric detection. PARP: full length PARP
(116 kDa), C-PARP: cleaved PARP fragment (89 kDa). Values indicate percentage
of C-PARP (western blot) and percentage of sub-G1 cells (Flow cytometry).
(C) Cells were exposed to STS in combinationwith dilutions of z-VAD.fmk for 4 h.
DEVDase (caspase) activity was detected by z-DEVD.amc fluorogenic substrate
cleavage; FRase activity was detected by z-FR.amc fluorogenic substrate cleavage;
sub-G1 cells were detected by flow cytometry; PARP fragmentation was analyzed
by western blotting and the percentage of C-PARP was showed on the diagram.
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the lysates of cells exposed to N10 μM z-VAD.fmk (Fig. 3C),
indicating the presence of z-VAD.fmk resistant cathepsin-like
protease activity in U937 cells.
The involvement of cystein cathepsin proteases in STS+z-VAD.
fmk-generated cell death was tested by z-FA.fmk, the broad
spectrum inhibitor of cathepsins (B, L, H) [37]. In all three
([annexin V—PI], [sub-G1—PI uptake] and [SSC—DNA
content]) of the flow cytometric cell death profiles, z-FA.fmk
decreased the appropriate population of apoptotic cells (p=0.0002
in [sub-G1—PI uptake] profile) while increasing the necrotic
population ( p=0.0051 in [sub-G1—PI uptake] profile) inSTS+zVAD.fmk-treated samples (Fig. 4A–C); however, z-FA.
fmk was ineffective on STS-induced apoptosis (Fig. 4A–C)
and H2O2-induced necrosis (not shown). The z-FA.fmk-
augmented population of (SSClow, DNAnorm) necrotic cells in
[SSC—DNA content] profile shows the same decrease is SSC
intensity indicating that excess necrotic cells may follow the
same necrotic death pathway (Fig. 4B). Residual PARP cleav-
age in STS+z-VAD.fmk samples was eliminated by z-FA.fmk
treatment, while it was not affected in STS-generated samples
(Fig. 4D). Morphological signs of DNA condensation were
also extinguished by z-FA.fmk visualised in H–E-stained
preparations (Fig. 5A). Inhibition of apoptotic cell death and
inhibition of cathepsin activity in cell lysates was well corre-
lated over broad range of z-FA.fmk concentrations (Fig. 6A).
These results indicate that cystein cathepsin protease activity
is required for the apoptotic death program induced by STS in
caspase-compromised U937 cells.
3.4. STS-induced necrosis required Hsp90 chaperone activity
in caspase-compromised cells
RIP1 (Receptor Interacting Protein 1) kinase is a central
component of several necrotic signaling pathways [16] and
RIP1 protein, being the client of the Hsp90 chaperone, is down-
regulated by prolonged treatment with geldanamycin (GA)
[26,56], an inhibitor of Hsp90 [46].
We pretreatedU937 cells with GA for 12 h to ensure the down-
regulation of Hsp90 client proteins. In all three ([annexin V—PI],
[sub-G1—PI uptake] and [SSC—DNA content]) of the flow
cytometric cell death profiles, GA decreased the appropriate
population of necrotic cells (p=0.0032 in [sub-G1—PI uptake]
profile), while increasing the apoptotic population in STS+zVAD.
fmk-treated samples (Fig 4A–C), but did not change either STS-
induced apoptotic (Fig. 4A–C) or H2O2-induced necrotic cell
death (not shown). GA slightly augmented the cleavage of PARP
in STS+z-VAD.fmk samples in concordance with an enlarged
sub-G1 population (Fig. 4C, D) and increased the number of cells
with stage II nuclear morphology (Fig. 5A, C). Inhibition of
Hsp90 activity byGA is known to induce cell cycle arrest in G1 as
well as in G2/M phases [3]. We assessed and found that the two
functions of GA (modulation of the cell death and the cell cycle)
were similarly affected by GA dilutions, confirming that both
functions are related to inhibition of Hsp90 (Fig. 6B).
These results indicate that Hsp90 chaperone activity is
required for the necrotic death program induced by STS in the
caspase-compromised U937 cells.
3.5. GA and z-FA.fmk co-treatment rescued STS-induced
caspase-compromised cells by reducing mitochondrial and
lysosomal breakdown
So far, neither one of the two inhibitors (GA or z-FA.fmk)
inhibited cell death when used alone—they only switched one of
the cell death forms to the other. Next, we assessed if co-treatment
could abrogate the STS+z-VAD.fmk-provoked cell death.
We found that all hallmarks of apoptosis (annexin V
positivity and sub-G1 population) and necrosis (PI uptake and
Fig. 4. Regulation of the appearance of cell death forms induced by staurosporine. (A–D) U937 cells were exposed to STS (1 μM) in the presence or absence of z-VAD.
fmk (50 μM) for 8 h. Samples were preincubated with or without GA (1 μM) for 12 h and/or z-FA.fmk (z-FA) (1 μM) for 30 min. (A) Representative histograms of
annexin V-FITC and PI stained, unfixed samples detected by flow cytometry and evaluated in [Annexin V-FITC, PI] representation. (B) Representative histograms of
PI-stained, ethanol fixed samples detected by flow cytometry and evaluated in [SSC, DNA content] representation. The values indicate the percentage of cells in
marked regions. DMSO as vehicle was applied for control samples. (C) Column diagrams of data quantified in [sub-G1] and [PI uptake] flow cytometric
representations. Values are mean±SD (n=5). (D) Western blot analysis. PARP: full length PARP (116 kDa), C-PARP: cleaved PARP fragment (89 kDa).
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Fig. 5. GA+z-FA.fmk protected caspase-compromised cells from STS-induced cell death for prolonged time. (A–F) U937 cells were exposed to STS (1 μM) in the
presence or absence of z-VAD.fmk (50 μM) for 8 h. Samples were preincubated with or without GA (1 μM) for 12 h and/or z-FA.fmk (z-FA, FA) (1 μM) for 30 min.
Treated samples were harvested for light microscopic analysis at (A) 8 h and (B) 18 h. Black arrow: necrotic cells, white arrow: apoptotic cells, Z: zeiotic cells, M:
Mitotic cells. (C) Cell death was quantified as apoptosis and necrosis by light microscopic morphological analysis. Values are mean±SD (n=2). (D) Treated samples
were prepared according to [PI uptake] flow cytometric representation and the FSC (forward light scatter) intensity of PI unstained, vital cells was presented. DMSO as
vehicle (continuos line), STS+z-VAD (dotted line), STS+z-VAD+GA+FA (dashed line) (representative of n=5). (E, F) Representative histograms of annexin V-
FITC and PI-stained, unfixed samples detected by flow cytometry and evaluated in [Annexin V-FITC, PI] representation (E) 8 h and (F) 18 h after treatment. N:
necrotic cells, PM: post mortem cells, A: apoptotic cells. Values are indicate the percentage of cells in the quadrate regions (n=2). (G) Diagram shows long-term
kinetics of absolute percentage of PI+ cells measured with Flow cytometry in [PI uptake] flow cytometric representation (n=2). Samples were treated with DMSO as
vehicle (open triangle), STS+z-VAD (black triangle), STS+z-VAD+GA+FA (black square).
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inhibitors (Fig. 4A, B) after 8 h of treatment. The abrogation of
cell death (both apoptotic and necrotic) was significant in the
[sub-G1—PI-uptake] profile (Pb0.00002) (Fig. 4C) and the[SSC—DNA content] profile (not shown). GA+z-FA.fmk had
no significant effect on apoptosis induced by STS (Fig. 4C) or
on necrosis induced by H2O2 (not shown), underlining the
diversity in death pathways. Co-treated cells preserved the
Fig. 6. Correlation of the effect of z-FA.fmk and GA on different cell functions.
U937 cells were pre-incubated with various dilutions of (A): z-FA.fmk
for 30 min or (B): geldanamycin for 12 h, then exposed to DMSO as control
or STS+z-VAD.fmk for 8 h. (A) Cathepsin activity were detected in samples
treated with z-FA.fmk dilutions by z-FR-AMC (–+–) and z-RR-AMC (–x–)
fluorogenic substrates and the slope of the linear activity values were plotted as
percentage compared to control (no z-FA.fmk added) sample. Apoptosis was
determined in the [sub-G1] flow cytometric representation (filled up triangles),
and absolute percentage of these cells were plotted. (B) Cell cycle distribution
was determined by flow cytometry and absolute percentage of cells of early S
phase was plotted (–x–). Necrosis was evaluated in the [PI uptake] flow
cytometric representation and absolute percentage of these cells was plotted
(open down triangles). Representative of two independent experiments is
presented.
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compared to control cells (Fig. 5A, B). The flow cytometric
forward (light) scatter (FSC) value is usually proportional to the
volume of viable cells. Detection of the FSC parameter
confirmed that GA+z-FA.fmk could not protect STS+z-VAD.
fmk-generated cell volume loss (Fig. 5D). Nevertheless, the
viability of STS+z-VAD.fmk-exposed cells was preserved for a
long time with GA+z-FA.fmk, at least partially, which was
assessed by morphology (Fig. 5A, B), [annexin V—PI] (Fig.
5 E, F) and [PI uptake] (Fig. 5G) flow cytometric death profiles.
As volume loss is an upstream phenomenon in cell death, we
tested whether the mitochondria and/or lysosomal functions
were preserved with GA+z-FA.fmk. We assessed mitochondrial
membrane potential with DiOC6(3) staining (Fig. 7A, B) and
the extent of acidic (endo-lysosomal) compartments with acri-
dine orange (AO) (Fig. 7E, F) using flow cytometry. STS alone
induced a moderate decrease of both mitochondrial membrane
potential and volume of acidic compartments. STS+z-VAD.fmk
reduced both stainings even more (Fig. 7A, E). However, z-FA.
fmk and GA combination prevented the reduction of bothstainings induced by STS+z-VAD.fmk, but not in the case when
z-VAD.fmk was omitted from STS (Fig. 7B, F). A represen-
tation of mean fluorescence intensities shows that GA+z-FA.
fmk significantly preserved both the mitochondrial membrane
potential and the volume of acidic compartments in U937 cells
exposed to STS+z-VAD.fmk (Fig. 7D and H) but not in cells
exposed to STS (Fig. 7C and G) or H2O2 (data not shown).
4. Discussion
In this study we used STS as a model compound for induction
of cell death via the intrinsic mitochondria-apoptosome
mediated pathway. We have shown that STS, in the presence
of z-VAD.fmk caspase inhibitor, evoked apoptotic as well as
necrotic forms of cell death in parallel in distinct cells but not the
mixed phenotype in individual cells. For assessment apoptotic
and necrotic traits in individual cells we introduced a new flow
cytometric death profile by correlating SSC and DNA content
changes in ethanol fixed cells. This technique allowed us to
complement the usual dye uptake assay for detection of necrosis.
The two methods using them in parallel may allow one to
discriminate between primary necrotic and secondary necrotic
cell exploiting that primary necrotic cells usually do not bear
immediate small scale DNA fragmentation while secondary
necrotic cell do. Furthermore, primary necrotic cells arising in
case of caspase inhibition loss their SSC value rapidly, while
secondary necrotic cells only gradually (Fig. 2D, STS 20 h).
However, post-mortem changes in dead cells might deteriorate
these differences due to serum DNases and proteases as
demonstrated in Fig. 5E, F.
Using this and other flow cytometric death profiles com-
plemented with morphological investigation and PARP proces-
sing test we found that both z-FA.fmk, the inhibitor of cystein
proteases and GA, the inhibitor of Hsp90 chaperone activity
switched one of the cell death form to the other in STS-induced
caspase-compromised U937 cells. Furthermore, z-FA.fmk and
GA combination halted cell death by preserving mitochondrial
membrane potential and the acidic volume of cells (Fig. 7)
while not preventing cell shrinkage (Fig. 5).
Searching for biochemical markers typical for apoptosis or
necrosis in this experimental circumstances we found that the
applied dose of z-VAD.fmk completely suppressed the activity
of the so-called executioner caspases (DEVDases) induced by
STS. Nevertheless, nucleosomal DNA fragmentation, PARP
cleavage typical in caspase-mediated apoptosis [35] and
morphological condensation of DNA was not abrogated by z-
VAD.fmk, those were only initiated with a delayed kinetics.
Application of z-FA.fmk abolished all the three detected
features of apoptosis. This indicates a role for cystein proteases
in mediating the apoptotic signal provoked by STS in caspase-
compromised U937 cells. The more precise characterization of
this cystein protease as cathepsins comes from the results that
(a) z-VAD.fmk exposed cells retained a fractional FRase
activity, featuring a broader range of cystein cathepsins, while
lost RRase activity, that specify cathepsin B primarily [37]; (b)
z-FA.fmk inhibited both apoptosis and FRase activity in cells at
the same concentrations.
Fig. 7. Protection of cells from staurosporine-induced cell deathwas accompaniedwith prevention ofmitochondrial and lysosomal breakdown.U937 cells were exposed
to STS (1 μM) in the presence or absence of z-VAD.fmk (50 μM) for 8 h. Samples were preincubated with or without GA (1 μM) for 12 h and/or z-FA.fmk (1 μM) for
30 min. (A–B) Representative histograms of DiOC6(3) and PI-stained samples detected by flow cytometry and presented in [DiOC6(3)] representation. (E–F)
Representative histograms of AO-stained samples detected by flow cytometry and presented in [AO red] representation. Samples were treated with (A, E) DMSO as
control or with (B, F) GA+z-FA.fmk together with DMSO as control (dotted lines), STS (dashed lines) or STS+z-VAD.fmk (continuos lines). (C–D) Column diagrams
of data quantified in [DiOC6(3)] flow cytometric representation as mean fluorescence intensity of the whole gated cell population. (G–H) Column diagrams of data
quantified in [AO red] flow cytometric representation as mean fluorescence intensity of the whole gated cell population. Values are mean±SD (n=3).
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cathepsin B, -H, -L, -S cystein cathepsins at moderate while
cathepsin D at excess level [23,30]. However, an activity-based
probe for cystein cathepsin visualized other bands in endocytic
fraction. It is not clear that these proteases can directly access
and process the appropriate substrate proteins required for
apoptotic transformation as do effector caspases [28]. Purified
cathepsins could not directly activate caspases [47], but isolated
lysosomes have done [27]. Purified cathepsin B and L could
processed cPLA2 [17], purified cathepsin B, -D and -G cleaved
PARP [20] but providing fragments with different lengths
compared to caspases. However, again isolated lysosomes could
yield the typical apoptotic fragment length of PARP [20] or the
Bid fragment that functionally identical with the caspase-pro-
cessed one [47]. Interestingly, Brockhaus and Brüne found in
U937 cells that NO-releasing compounds induced DNA frag-
mentation and U1 snRNP cleavage (at 4 h treatment) that were
abrogated by using a pan caspase inhibitor, but the typical
apoptotic fragment length of PARP (85 kDa) appeared with
delayed kinetics (after 8 h treatment) [5]. But there is no
information about the role of cathepsins in this phenomenon.
Indirect evidences indicate that TNF-α in hepatocytes [59] or
bortezomib in pancreatic cancer cells [61] stimulated the release
of cathepsin (B) from lysosomes that was required for caspase 2
activation and mitochondrial permeabilization providing the
source of caspase-dependent and -independent effector mole-
cules of apoptosis, including AIF [12] and endonuclease G [34].
Caspase 2 is less sensitive for z-VAD.fmk than other caspases
[19], therefore it is possible that caspase 2 can serve as a pro-
teolytic dart for cathepsins. PIDDosome forms a platform foractivation of caspase 2 [53] and RIP1 as well [29]. Autoproteo-
lysis of PIDD at two different sites provides fragments for
preferable caspase 2 or RIP1 activation [52]. It is an intriguing
hypothesis that the PIDDosome can realize the suggested
bifurcation point where cathepsin mediated proteolysis set up
the decision making point of cells to commit apoptotic or ne-
crotic suicide when executioner caspases are halted by drugs or
IAP proteins. This and other [40] possible involvements of
caspase activities in the execution of cell death without
DEVDase activity forced us to consistently apply the terminol-
ogy as caspase-compromised or caspase-inhibited instead of
caspase-independent for z-VAD.fmk-treated cells in this study.
The permeabilization of lysosomes may serve for another
putative bifurcation point. It is proposed that low grade leakage of
lysosomes preferably initiates apoptotic signaling, while high
grade disruption of lysosomes favorably promotes necrosis [7].
Permeabilization is advanced by excess oxidation of lipids and
proteins [51] while Hsp 70 expression favors stabilization of the
lysosomes probably assisting the selective permeability of their
membrane [39]. Abruption of Hsp90 function by GA provokes
Hsp70 upregulation that may preserve lysosomes and suppress
necrosis. However this scenario is unlikely because GA pre-
treatment could not prevent STS+z-VAD.fmk-generated decline
of AO red staining (Fig. 7H) indicating of lysosomal damage, at
least abruption of H+ homeostasis. Interestingly, mitochondrial
depolarization was partially prevented by prolonged exposure
of U937 cell to GA (Fig. 7D). Another difficulty of this hypoth-
esis comes up with considering how disruption of the activity of
cathepsins by z-FA.fmk will assist for necrosis instead of
apoptosis.
1556 G. Imre et al. / Biochimica et Biophysica Acta 1773 (2007) 1546–1557Nevertheless, our results are consistent with the interpretation
of the existence of a bifurcation point in the STS-induced death
signal pathway positioned at or upstream of mitochondrial and
lysosomal breakdown. This pathway may dominate in cells
where executioner caspases are suppressed. Caspase-compro-
mised states can occur in physiological and pathological cir-
cumstances by over-expression of inhibitor of apoptosis proteins
(IAPs) [13], over-production of nitric oxide (NO) that may
nitrosylates and inactivates caspases [6,41], or application of
drugs that result in reactive metabolite formation and oxidative
stress e.g. the case of acetaminophen [24]. The use of caspase
inhibitors can partially mimic these patho-physiological cases.
Furthermore, consideration of caspase inhibitors (even with
broader specificity) as potential pharmaceutical products
requires exploration of the molecular mechanisms of “caspase-
independent cell death.
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